Nϵ-Carboxymethyllysine Increases the Expression of miR-103/143 and Enhances Lipid Accumulation in 3T3-L1 Cells

Journal of Cellular Biochemistry

Volumn , Issue , 2016, Pages 2413-2422

  Holik, Ann Katrin ^a   Lieder, Barbara ^a   Kretschy, Nicole ^a   Somoza, Mark M ^a   Held, Sandra ^b   Somoza, Veronika ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

3T3 L1; ADIPOGENESIS; microRNA; N epsilon carboxymethyllysine

Indexed keywords

6 N CARBOXYMETHYLLYSINE; FATTY ACID; GLUCOSE; MICRORNA; MICRORNA 103; MICRORNA 143; UNCLASSIFIED DRUG;

3T3 CELL LINE; ADIPOGENESIS; AKT1 GENE; ANIMAL CELL; ARTICLE; CAV1 GENE; CELL VIABILITY; CONTROLLED STUDY; FATTY ACID TRANSPORT; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; GLYCATION; LIPID STORAGE; MOUSE; MTT ASSAY; NONHUMAN; PI3K GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING;

EID: 84984972872     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25576     Document Type: Article

References (58)

1. Agbavwe C, Kim C, Hong D, Heinrich K, Wang T, Somoza MM. 2011. Efficiency, error, and yield in light-directed maskless synthesis of DNA microarrays. J Nanobiotechnology 9:57.
2. Ahmed MU, Thorpe SR, Baynes JW. 1986. Identification of N-epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J Biol Chem 261:4889–4894.
3. Birlouez-Aragon I, Saavedra G, Tessier FJ, Galinier A, Ait-Ameur L, Lacoste F, Niamba CN, Alt N, Somoza V, Lecerf JM. 2010. A diet based on high-heat-treated foods promotes risk factors for diabetes mellitus and cardiovascular diseases. Am J Clin Nutr 91:1220–1226.
4. Cai WJ, Ramdas M, Zhu L, Chen X, Striker GE, Vlassara H. 2012. Oral advanced glycation endproducts (AGEs) promote insulin resistance and diabetes by depleting the antioxidant defenses AGE receptor-1, and sirtuin 1. P Natl Acad Sci USA 109:15888–15893.
5. Chen CY, Abell AM, Moon YS, Kim KH. 2012. An advanced glycation end product (AGE)-receptor for AGEs (RAGE) axis restores adipogenic potential of senescent preadipocytes through modulation of p53 protein function. J Biol Chem 287:44498–44507.
6. Farmer SR. 2006. Transcriptional control of adipocyte formation. Cell Metab 4:263–273.
7. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. 2002. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290:1084–1089.
8. Faust IM, Johnson PR, Stern JS, Hirsch J. 1978. Diet-induced adipocyte number increase in adult rats: A new model of obesity. Am J Physiol 235:E279–E286.
9. Friess U, Waldner M, Wahl HG, Lehmann R, Haring HU, Voelter W, Schleicher E. 2003. Liquid chromatography-based determination of urinary free and total N(epsilon)-(carboxymethyl)lysine excretion in normal, and diabetic subjects. J Chromatogr B Analyt Technol Biomed Life Sci 794:273–280.
10. Frost RJ, Olson EN. 2011. Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. P Natl Acad Sci USA 108:21075–21080.
11. Gaens KHJ, Goossens GH, Niessen PM, van Greevenbroek MM, van der Kallen CJH, Niessen HW, Rensen SS, Buurman WA, Greve JWM, Blaak EE, van Zandvoort MA, Bierhaus A, Stehouwer CDA, Schalkwijk CG. 2014. N-epsilon-(carboxymethyl) lysine- receptor for advanced glycation end product axis is a key modulator of obesity-Induced dysregulation of adipokine expression and insulin resistance. Arterioscl Throm Vas 34:1199–1208.
12. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. 2006. MiRBase: microRNA sequences, targets, and gene nomenclature. Nucleic Acids Res 34:D140–D144.
13. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. 2008. MiRBase: Tools for microRNA genomics. Nucleic Acids Res 36:D154–D158.
14. Han J, Farmer SR, Kirkland JL, Corkey BE, Yoon R, Pirtskhalava T, Ido Y, Guo W. 2002. Octanoate attenuates adipogenesis in 3T3-L1 preadipocytes. J Nutr 132:904–910.
15. Hanssen NM, Engelen L, Ferreira I, Scheijen JL, Huijberts MS, van Greevenbroek MM, van der Kallen CJ, Dekker JM, Nijpels G, Stehouwer CD, Schalkwijk CG. 2013. Plasma levels of advanced glycation endproducts Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine, and pentosidine are not independently associated with cardiovascular disease in individuals with or without type 2 diabetes: The Hoorn and CODAM studies. J Clin Endocrinol Metab 98:E1369–E1373.
16. Harwood HJ. 2012. The adipocyte as an endocrine organ in the regulation of metabolic homeostasis. Neuropharmacology 63:57–75.
17. Hausman DB, DiGirolamo M, Bartness TJ, Hausman GJ, Martin RJ. 2001. The biology of white adipocyte proliferation. Obes Rev 2:239–254.
18. Hellwig M, Matthes R, Peto A, Lobner J, Henle T. 2014. N-epsilon-fructosyllysine and N-epsilon-carboxymethyllysine, but not lysinoalanine, are available for absorption after simulated gastrointestinal digestion. Amino Acids 46:289–299.
19. Holik AK, Rohm B, Somoza MM, Somoza V. 2013. N(epsilon)-carboxymethyllysine (CML), a Maillard reaction product, stimulates serotonin release and activates the receptor for advanced glycation end products (RAGE) in SH-SY5Y cells. Food Funct 4:1111–1120.
20. Hull GLJ, Woodside JV, Ames JM, Cuskelly GJ. 2012. N-epsilon-(carboxymethyl)lysine content of foods commonly consumed in a western style diet. Food Chemistry 131:170–174.
21. Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, Ueda S, Horiuchi S. 1996. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35:8075–8083.
22. Jia XM, Chang TJ, Wilson TW, Wu LY. 2012. Methylglyoxal mediates adipocyte proliferation by increasing phosphorylation of Akt1. PLoS ONE 7:e36610.
23. Jordan SD, Kruger M, Willmes DM, Redemann N, Wunderlich FT, Bronneke HS, Merkwirth C, Kashkar H, Olkkonen VM, Bottger T, Braun T, Seibler J, Bruning JC. 2011. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol 13:434–446.
24. Jousse F, Jongen T, Agterof W, Russell S, Braat P. 2002. Simplified kinetic scheme of flavor formation by the Maillard reaction. J Food Sci 67:2534–2542.
25. Kim W, Kyung Lee E. 2012. Post-transcriptional regulation in metabolic diseases. RNA Biol 9:772–780.
26. Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du Yan S, Hofmann M, Yan SF, Pischetsrieder M, Stern D, Schmidt AM. 1999. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 274:31740–31749.
27. Kozomara A, Griffiths-Jones S. 2011. MiRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39:D152–D157.
28. Lieuw AFML, van Hinsbergh VW, Teerlink T, Barto R, Twisk J, Stehouwer CD, Schalkwijk CG. 2004. Increased levels of N(epsilon)-(carboxymethyl)lysine and N(epsilon)-(carboxyethyl)lysine in type 1 diabetic patients with impaired renal function: Correlation with markers of endothelial dysfunction. Nephrol Dial Transplant 19:631–636.
29. Makita Z, Vlassara H, Rayfield E, Cartwright K, Friedman E, Rodby R, Cerami A, Bucala R. 1992. Hemoglobin-AGE: A circulating marker of advanced glycosylation. Science 258:651–653.
30. McGregor RA, Choi MS. 2011. MicroRNAs in the regulation of adipogenesis and obesity. Curr Mol Med 11:304–316.
31. Monden M, Koyama H, Otsuka Y, Morioka T, Mori K, Shoji T, Mima Y, Motoyama K, Fukumoto S, Shioi A, Emoto M, Yamamoto Y, Yamamoto H, Nishizawa Y, Kurajoh M, Yamamoto T, Inaba M. 2013. Receptor for advanced glycation end products regulates adipocyte hypertrophy and insulin sensitivity in mice: Involvement of Toll-like receptor 2. Diabetes 62:478–489.
32. Peng Y, Yu S, Li H, Xiang H, Peng J, Jiang S. 2014. MicroRNAs: Emerging roles in adipogenesis and obesity. Cell Signal 26:1888–1896.
33. Piperi C, Goumenos A, Adamopoulos C, Papavassiliou AG. 2015. AGE/RAGE signaling regulation by miRNAs: Associations with diabetic complications and therapeutic potential. Int J Biochem Cell B 60:197–201.
34. Ramirez-Zacarias JL, Castro-Munozledo F, Kuri-Harcuch W. 1992. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O. Histochemistry 97:493–497.
35. Riedel A, Pignitter M, Hochkogler CM, Rohm B, Walker J, Bytof G, Lantz I, Somoza V. 2012. Caffeine dose-dependently induces thermogenesis but restores ATP in HepG2 cells in culture. Food Funct 3:955–964.
36. Rohm B, Holik AK, Kretschy N, Somoza MM, Ley JP, Widder S, Krammer GE, Marko D, Somoza V. 2015. Nonivamide enhances miRNA let-7d expression and decreases adipogenesis PPARgamma expression in 3T3-L1 cells. J Cell Biochem 116:1153–1163.
37. Ruijter JM, Ramakers C, Hoogaars WM, Karlen Y, Bakker O, van den Hoff MJ, Moorman AF. 2009. Amplification efficiency: Linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res 37:e45.
38. Sack M, Kretschy N, Rohm B, Somoza V, Somoza MM. 2013. Simultaneous light-directed synthesis of mirror-image microarrays in a photochemical reaction cell with flare suppression. Anal Chem 85:8513–8517.
39. Schmid K, Haslbeck M, Buchner J, Somoza V. 2008. Induction of heat shock proteins and the proteasome system by casein-N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)lysine in Caco-2 cells. Ann NY Acad Sci 1126:257–261.
40. Sebekova K, Saavedra G, Zumpe C, Somoza V, Klenovicsova K, Birlouez-Aragon I. 2008. Plasma concentration and urinary excretion of N-epsilon-(carboxymethyl)lysine in breast milk- and formula-fed infants. Ann NY Acad Sci 1126:177–180.
41. Somoza V, Wenzel E, Weiss C, Clawin-Radecker I, Grubel N, Erbersdobler HF. 2006. Dose-dependent utilisation of casein-linked lysinoalanine, N(epsilon)-fructoselysine and N(epsilon)-carboxymethyllysine in rats. Mol Nutr Food Res 50:833–841.
42. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, Blomqvist L, Hoffstedt J, Naslund E, Britton T, Concha H, Hassan M, Ryden M, Frisen J, Arner P. 2008. Dynamics of fat cell turnover in humans. Nature 453:783–787.
43. Spandidos A, Wang X, Wang H, Dragnev S, Thurber T, Seed B. 2008. A comprehensive collection of experimentally validated primers for polymerase chain reaction quantitation of murine transcript abundance. BMC Genomics 9:633.
44. Spandidos A, Wang X, Wang H, Seed B. 2010. PrimerBank: A resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res 38:D792–D799.
45. Sun T, Fu M, Bookout AL, Kliewer SA, Mangelsdorf DJ. 2009. MicroRNA let-7 regulates 3T3-L1 adipogenesis. Mol Endocrinol 23:925–931.
46. Teerlink T, Barto R, Ten Brink HJ, Schalkwijk CG. 2004. Measurement of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry. Clin Chem 50:1222–1228.
47. Trajkovski M, Hausser J, Soutschek J, Bhat B, Akin A, Zavolan M, Heim MH, Stoffel M. 2011. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474:649–653.
48. Tuomi JM, Voorbraak F, Jones DL, Ruijter JM. 2010. Bias in the Cq value observed with hydrolysis probe based quantitative PCR can be corrected with the estimated PCR efficiency value. Methods 50:313–322.
49. Unoki H, Bujo H, Yamagishi S, Takeuchi M, Imaizumi T, Saito Y. 2007. Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes. Diabetes Res Clin Pract 76:236–244.
50. Uribarri J, Cai W, Sandu O, Peppa M, Goldberg T, Vlassara H. 2005. Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann NY Acad Sci 1043:461–466.
51. Uribarri J, Woodruff S, Goodman S, Cai WJ, Chen X, Pyzik R, Yong A, Striker GE, Vlassara H. 2010. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 110:911–916.
52. Vlassara H, Cai WJ, Crandall J, Goldberg T, Oberstein R, Dardaine V, Peppa M, Rayfield EJ. 2002. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. P Natl Acad Sci USA 99:15596–15601.
53. Wang H, Ach RA, Curry B. 2007. Direct and sensitive miRNA profiling from low-input total RNA. RNA 13:151–159.
54. Wang X, Seed B. 2003. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31:e154.
55. Xie H, Lim B, Lodish HF. 2009. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58:1050–1057.
56. Xie J, Reverdatto S, Frolov A, Hoffmann R, Burz DS, Shekhtman A. 2008. Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J Biol Chem 283:27255–27269.
57. Yang SJ, Chen CY, Chang GD, Wen HC, Chang SC, Liao JF, Chang CH. 2013. Activation of Akt by advanced glycation end products (AGEs): Involvement of IGF-1 receptor and caveolin-1. PLoS ONE 8:e58100.
58. Zill H, Bek S, Hofmann T, Huber J, Frank O, Lindenmeier M, Weigle B, Erbersdobler HF, Scheidler S, Busch AE, Faist V. 2003. RAGE-mediated MAPK activation by food-derived AGE and non-AGE products. Biochem Biophys Res Commun 300:311–315.